However, a long-term goal would be to use oncolytic viruses to deliver the NA-Fc in conjunction with adoptive NK cells to combine the powerful cancer cell killing properties of an oncolytic virus with enhanced elimination by adoptively transferred, donor-derived, hyperactive NK cells such as PM21-NK cells. The gene discussed is XK; the disease is cancer.